MX2015001751A - Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes. - Google Patents

Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes.

Info

Publication number
MX2015001751A
MX2015001751A MX2015001751A MX2015001751A MX2015001751A MX 2015001751 A MX2015001751 A MX 2015001751A MX 2015001751 A MX2015001751 A MX 2015001751A MX 2015001751 A MX2015001751 A MX 2015001751A MX 2015001751 A MX2015001751 A MX 2015001751A
Authority
MX
Mexico
Prior art keywords
interest
compound
transformed bacteria
topical composition
bacteria expressing
Prior art date
Application number
MX2015001751A
Other languages
English (en)
Inventor
Noga Qvit-Raz
Tahel Altman
Original Assignee
Topgenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topgenix Inc filed Critical Topgenix Inc
Publication of MX2015001751A publication Critical patent/MX2015001751A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

Se describen composiciones que comprenden una población de bacterias transformadas formuladas para aplicación tópica a un sujeto. La población de bacterias transformadas es creada a partir de bacterias no patógenas y transformadas para expresar un compuesto de interés para un propósito terapéutico o cosmético. En una modalidad, la composición es para protección de la piel de rayos ultravioleta.
MX2015001751A 2012-08-07 2013-08-07 Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes. MX2015001751A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261680620P 2012-08-07 2012-08-07
US201361836594P 2013-06-18 2013-06-18
PCT/US2013/054026 WO2014025938A1 (en) 2012-08-07 2013-08-07 Topical composition comprising transformed bacteria expressing a compound of interest

Publications (1)

Publication Number Publication Date
MX2015001751A true MX2015001751A (es) 2015-11-13

Family

ID=48980379

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015001751A MX2015001751A (es) 2012-08-07 2013-08-07 Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes.

Country Status (8)

Country Link
US (3) US9234204B2 (es)
EP (1) EP2882494A1 (es)
JP (1) JP2015525800A (es)
KR (1) KR20150065170A (es)
AU (1) AU2013299605A1 (es)
IL (1) IL237149A0 (es)
MX (1) MX2015001751A (es)
WO (1) WO2014025938A1 (es)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
US9408880B2 (en) 2013-12-20 2016-08-09 Katherine Rose Kovarik Method and system for prevention and treatment of allergic and inflammatory diseases
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
BR112014004065A2 (pt) * 2011-08-22 2017-03-14 Glycotope Gmbh micro-organismos carregando um antígeno de tumor
AU2013235340B2 (en) 2012-03-17 2019-05-23 The Regents Of The University Of California Fast diagnosis and personalized treatments for acne
US9234204B2 (en) 2012-08-07 2016-01-12 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
JP6090854B2 (ja) * 2013-11-15 2017-03-08 株式会社東洋新薬 コラーゲン産生促進用組成物
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
KR102148740B1 (ko) * 2014-05-13 2020-08-27 각코우호우징 기타사토켄큐쇼 미생물을 사용한 미코스포린 유사 아미노산을 생산하는 방법
MA40057A (fr) * 2014-05-30 2015-12-03 Azitra Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants
EP3164196B1 (en) 2014-06-17 2021-08-18 Topgenix, Inc. Topical formulations for uv protection
CA2950945A1 (en) * 2014-06-17 2015-12-23 Xycrobe Therapeutics, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
GB201413333D0 (en) * 2014-07-28 2014-09-10 Azotic Technologies Ltd Plant inoculation
TWI565799B (zh) * 2014-12-09 2017-01-11 財團法人農業科技研究院 乳酸菌菌株、其質體、及其衍生之載體
KR102532172B1 (ko) * 2015-10-05 2023-05-17 주식회사 엘지생활건강 고염 미생물을 포함하는 화장료 조성물
JP2019006679A (ja) * 2015-11-11 2019-01-17 長瀬産業株式会社 新規マイコスポリン様アミノ酸
WO2017091694A1 (en) * 2015-11-24 2017-06-01 Memorial Sloan-Kettering Cancer Center Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitis
US10086024B2 (en) 2015-11-30 2018-10-02 Joseph E. Kovarik Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
US10933128B2 (en) 2015-11-30 2021-03-02 Joseph E. Kovarik Method and system for protecting honey bees from pesticides
US10568916B2 (en) 2015-11-30 2020-02-25 Joseph E. Kovarik Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
US10675347B2 (en) 2015-11-30 2020-06-09 Joseph E. Kovarik Method and system for protecting honey bees from fipronil pesticides
US11529412B2 (en) 2015-11-30 2022-12-20 Seed Health, Inc. Method and system for protecting honey bees from pesticides
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
WO2017184992A1 (en) 2016-04-21 2017-10-26 Naked Biome, Inc. Compositions and methods for treatment of skin disorders
GB201611486D0 (en) * 2016-06-30 2016-08-17 Promovita Ingredients Ltd Composition for treatment and/or nutrition of poultry
KR101734960B1 (ko) * 2016-08-30 2017-05-12 (주)코엔바이오 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 류코노스톡 홀잡펠리 균주 및 이를 포함하는 조성물
EP3585356A4 (en) * 2017-02-27 2020-11-04 Continuum Group LLC SUN SCREEN
WO2018183685A1 (en) * 2017-03-29 2018-10-04 President And Fellows Of Harvard College Methods of regulating gene expression in a cell
US11103443B2 (en) * 2017-05-22 2021-08-31 Dermala Compositions and methods for preventing, slowing, and reversing skin aging
KR101911442B1 (ko) 2017-07-13 2018-10-24 (주)잇츠한불 신규한 바실러스 제주엔시스 hb-20 균주 및 이를 이용한 화장료 조성물
KR101911186B1 (ko) 2017-08-16 2018-10-25 씨제이제일제당 (주) 마이코스포린 유사 아미노산을 생산하는 미생물 및 이를 이용한 마이코스포린 유사 아미노산의 생산방법
WO2019094447A2 (en) * 2017-11-07 2019-05-16 Algenol Biotech LLC Production of mycosporine-like amino acids in cyanobacteria
AU2019223439A1 (en) * 2018-02-24 2020-09-10 Clearskin Ltd Compositions, devices, systems, kits and methods for the treatment of a skin condition
KR102118989B1 (ko) * 2018-03-05 2020-06-05 주식회사 엠디헬스케어 엔히드로박터 세균 유래 나노소포 및 이의 용도
JP7188447B2 (ja) 2018-09-28 2022-12-13 株式会社村田製作所 電磁波吸収剤、日焼け止め剤、光学部品、メガネ、及び電磁波吸収剤の製造方法
KR101961149B1 (ko) * 2018-11-30 2019-03-25 주식회사 아미코스메틱 락토바실러스 파라플란타룸 ami-1101 균주 및 이의 용도
CN109528530A (zh) * 2019-01-10 2019-03-29 向妮娟 保湿、抗氧化护肤组合物及其制备方法和应用
KR101975031B1 (ko) * 2019-04-02 2019-05-07 (주)에이투젠 신규한 비피도박테리움 롱검 atg-f5 균주 또는 이를 포함하는 화장료 조성물
US11851644B2 (en) 2019-05-02 2023-12-26 University Of Rhode Island Board Of Trustees Marine bacteria formulation useful in aquaculture
WO2020231426A1 (en) * 2019-05-15 2020-11-19 Algenol Biotech LLC Production of mycosporine-like amino acids employing enhanced production strains and novel enzymes
US11739337B2 (en) 2019-09-06 2023-08-29 Oregon State University Gadusol derivative production in bacteria
KR102273234B1 (ko) * 2020-05-08 2021-07-06 코스맥스 주식회사 코쿠리아 바리안스 균주 및 그의 피부 상태 개선 용도
US20210393510A1 (en) * 2020-06-23 2021-12-23 Crown Laboratories, Inc. Probiotic skin formulations
CN111893069B (zh) * 2020-08-12 2022-05-13 广东海洋大学 一株高效去除亚硝酸盐的解淀粉盐水球菌hl-6
EP4262997A1 (en) * 2020-12-18 2023-10-25 L'oreal Extract of bacteria of the genus sphingomonas
FR3117776B1 (fr) * 2020-12-18 2024-03-08 Oreal Extrait de bactérie du genreSphingomonas
KR102529325B1 (ko) * 2020-12-28 2023-05-08 코스맥스 주식회사 바이셀라 시바리아 균주 및 이의 용도
KR102480527B1 (ko) * 2020-12-30 2022-12-23 코스맥스 주식회사 코쿠리아 팔루스트리스 균주 및 그의 모발 또는 두피 상태 개선 용도
KR102495401B1 (ko) * 2020-12-30 2023-02-06 코스맥스 주식회사 이멜라 루테아 균주 및 그의 모발 또는 두피 상태 개선 용도
KR102495402B1 (ko) * 2020-12-30 2023-02-06 코스맥스 주식회사 버크홀데리아 비에트나미엔시스 균주 및 그의 모발 또는 두피 상태 개선 용도
KR102467931B1 (ko) * 2020-12-30 2022-11-16 코스맥스 주식회사 브레비바실러스 보스테렌시스 균주 및 그의 모발 또는 두피 상태 개선 용도
KR102480526B1 (ko) * 2020-12-30 2022-12-23 코스맥스 주식회사 다이어트지아 신나메아 균주 및 그의 모발 또는 두피 상태 개선 용도
KR102495403B1 (ko) * 2020-12-30 2023-02-06 코스맥스 주식회사 데이노코커스 우루무치엔시스 균주 및 그의 모발 또는 두피 상태 개선 용도
KR102495400B1 (ko) * 2020-12-30 2023-02-06 코스맥스 주식회사 노보스핑고비움 후미 균주 및 그의 모발 또는 두피 상태 개선 용도
WO2022187271A1 (en) * 2021-03-01 2022-09-09 Gadusol Laboratories, Inc. Gadusol and gadusporine compound formulations for topicals
KR102314736B1 (ko) * 2021-04-27 2021-10-21 주식회사 비피도 피부염증 개선 및 피부장벽 강화용 조성물
CN113337436A (zh) * 2021-06-09 2021-09-03 中国科学院新疆生态与地理研究所 一种尿素分解菌及其选育方法和应用
KR102411240B1 (ko) * 2021-10-18 2022-06-22 큐티스바이오 주식회사 파이시코쿠스 제주엔시스의 피부 상태 개선 용도
KR102361015B1 (ko) * 2021-10-18 2022-02-14 큐티스바이오 주식회사 스핑고모나스 올레이의 피부 상태 개선 용도
FR3133312A1 (fr) 2022-03-08 2023-09-15 Basf Beauty Care Solutions France Sas Utilisation cosmétique ou dermatologique de Sphingomonas glacialis et/ou d’une composition la comprenant
KR102523776B1 (ko) * 2022-09-27 2023-04-21 일동바이오사이언스(주) 비타민 a 생성능이 우수한 비피도박테리움 락티스 idcc 4301을 포함하는 조성물 및 건강기능식품

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259444A (en) 1972-06-07 1981-03-31 General Electric Company Microorganisms having multiple compatible degradative energy-generating plasmids and preparation thereof
WO1986002350A1 (en) 1984-10-10 1986-04-24 Australian Institute Of Marine Science Ultra violet agents
EP0311469A3 (en) 1987-09-02 1990-05-30 Plant Genetic Systems N.V. Transformed lactic acid bacteria
FR2658075B1 (fr) 1990-02-14 1992-05-07 Oreal Composition cosmetique filtrante photostable contenant un filtre uv-a et un beta,beta-diphenylacrylate ou alpha-cyano-beta,beta-diphenylacrylate d'alkyle.
US5207998A (en) 1991-05-07 1993-05-04 Richardson-Vicks Inc. Suncare compositions
CA2130453A1 (en) 1992-02-27 1993-09-02 Richard W. F. Le Page Heterologous gene expression in lactococcus, and the expression products threrefrom
US5620682A (en) 1993-03-25 1997-04-15 Bernel Chemical Co. Sunscreen compositions
IT1270123B (it) 1994-10-05 1997-04-28 Dompe Spa Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia
GB9521568D0 (en) 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
ATE493139T1 (de) 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
CA2251457A1 (en) 1998-10-23 2000-04-23 Norman Huner Compositions including naturally occurring compounds from plants, algae and cyanobacteria for protection against solar radiation
FR2803201B1 (fr) 1999-12-30 2004-11-26 Gelyma Extrait d'algue a activite filtrante vis a vis des radiations ultraviolettes
US20020119192A1 (en) 2000-09-22 2002-08-29 Vishwanathan Narayanan Badri Controlled release formulations for oral administration
PT1322318E (pt) 2000-10-06 2011-03-15 Oreal Utilização de bactérias ácido lácticas probióticas para prevenção de reacções inflamatórias ou alérgicas ou imunossupressão induzidas por radiações ultravioleta na pele
GB0028161D0 (en) 2000-11-17 2001-01-03 Natural Environment Res Personal care compositions
US7081442B2 (en) 2001-05-21 2006-07-25 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
EP1424990A2 (en) 2001-09-03 2004-06-09 Hadasit Medical Research Services And Development Ltd. The utilization of natural pigments from lichens, cyanobacteria, fungi and plants for sun protection
CH702571B1 (de) 2003-04-30 2011-07-29 Mibelle Ag Cosmetics Kosmetische Hautbehandlungsmittel und kosmetische Wirkstoffkombination zum Schutz gegen frühzeitige Hautalterung.
ITMI20041550A1 (it) 2004-07-29 2004-10-29 Proge Farm Srl Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
WO2006018446A2 (en) 2004-08-20 2006-02-23 Actogenix Nv Method to improve lactococcus preservation
EP1934328A1 (en) 2005-09-19 2008-06-25 Basf Se Microorganisms inhibiting the formation of foot malodor
BRPI0620508A2 (pt) 2005-11-14 2011-11-16 Tanning Res Lab Inc emulsão de água em óleo com filtro solar de alta eficiência
MX2012005891A (es) 2009-11-20 2012-11-23 Guerry L Grune Complejo a base de oxido de zinc, no toxico de amplio espectro estable a uva.
BR112012012476A2 (pt) * 2009-11-25 2015-09-15 Nestec Sa "composições nutritivas incluindo um componente de alta proteína e nucleotídeos exôgenos"
FR2953408B1 (fr) 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
EP2364712B1 (en) 2010-03-11 2013-03-06 Kloarys Investment Ltd Topical cosmetic or pharmaceutical composition comprising probiotic lactobacillus strains and use of same
WO2011150127A2 (en) * 2010-05-25 2011-12-01 The Board Of Trustees Of The University Of Illinois Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
GB201009271D0 (en) 2010-06-02 2010-07-21 Promar As Compositions
US20140065209A1 (en) 2011-05-03 2014-03-06 Dupont Nutrition Biosciences Aps Probiotic bacteria for the topical treatment of skin disorders
EP2561853A1 (de) 2011-08-24 2013-02-27 PM-International AG Sonnenschutzspray mit Sonnenschutzfaktor SPF 20 bis SPF 30
US9376686B2 (en) * 2011-09-23 2016-06-28 Forsyth Dental Infirmary For Children Vaccine and therapeutic delivery system
CA2875165C (en) 2012-06-04 2019-11-19 Elkimia Imino compounds as protecting agents against ultraviolet radiations
US9234204B2 (en) 2012-08-07 2016-01-12 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest

Also Published As

Publication number Publication date
US9868957B2 (en) 2018-01-16
WO2014025938A1 (en) 2014-02-13
US20140044677A1 (en) 2014-02-13
IL237149A0 (en) 2015-04-30
KR20150065170A (ko) 2015-06-12
US9234204B2 (en) 2016-01-12
US20140044653A1 (en) 2014-02-13
US9453232B2 (en) 2016-09-27
EP2882494A1 (en) 2015-06-17
JP2015525800A (ja) 2015-09-07
US20160000701A1 (en) 2016-01-07
AU2013299605A1 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
MX2015001751A (es) Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes.
PH12015500825B1 (en) Substituted benzene compounds
PH12016502132A1 (en) Aryl-or heteroaryl-substituted benzene compounds
MX359475B (es) Composiciones antitranspirantes y desodorantes.
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
MX2013011922A (es) Compuestos de benceno substituido.
MX2013002382A (es) Composiciones cutaneas y metodos para su uso.
HK1211841A1 (en) Skin care compositions containing cotton and citrus-derived materials
PH12015502405A1 (en) Methods and compositions for wound healing
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
MX369822B (es) Composiciones para proporcionar una proteccion de filtro solar mejorada.
MX2014014517A (es) Composiciones topicas bajo la forma de un gel que contiene un retinoide particular solubilizado.
IN2014DE01078A (es)
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
MX2015004312A (es) Formulacion de aroma y fragancia (i).
IN2015MN00091A (es)
WO2014004178A3 (en) Compositions comprising substituted phenols and topical application thereof
FR2985186B1 (fr) Extrait polaire de kniphofia uvaria, composition cosmetique ou dermatologique en contenant, et ses utilisations
IN2015DN02646A (es)
IN2012DE00679A (es)
LV14516A (lv) Kosmētisks līdzeklis sejas ādas kopšanai
BR112013026594A2 (pt) composto, método para prover umectância a uma composição para cuidado pessoal, composição para cuidado dos cabelos e composição para o cuidado da pele
BR112013026601A2 (pt) composto, método para prover umectância a uma composição para cuidado pessoal, composição para cuidado dos cabelos e composição para o cuidado da pele